Spine Biologics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32 - PowerPoint PPT Presentation

About This Presentation
Title:

Spine Biologics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

Description:

According to the latest research report by IMARC Group, The global spine biologics market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Date added: 8 February 2024
Slides: 13
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Spine Biologics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32


1
Global Spine Biologics Market Research and
Forecast Report 2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Spine Biologics Market Global Industry
    Trends, Share, Size, Growth, Opportunity and
    Forecast 2024-2032," the global spine biologics
    market size reached US 2.1 Billion in 2023.
  • Spine biologics include various tools that are
    generally used for performing spine fusion
    surgery. They are commonly utilized to treat
    deformities that occur due to spine trauma,
    degenerative disorders, and tumors. These tools
    are usually manufactured using biomaterials,
    including ceramics, polymers and glasses, that
    are safe in nature.
  • They aid in promoting bone growth and the healing
    process while minimizing the disruption of soft
    tissues. Additionally, spine biologics is
    considered to be a preferred alternative to
    spinal orthoses since it reduces the requirement
    of additional surgical procedures.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/spine-biologics-market/
    requestsample

4
Report Description
  • Global Spine Biologics Market Trends
  • The global market is primarily driven by
    significant growth in the healthcare sector.
    Moreover, a considerable increase in investments
    from private and public agencies across numerous
    countries to upgrade the existing healthcare
    infrastructure is creating a positive outlook for
    the market. Along with this, the rising
    prevalence of chronic and acute spinal disorders
    among the masses is providing a boost to the
    market growth across the globe. In line with
    this, the increasing geriatric population, which
    is more susceptible to musculoskeletal ailments,
    is also propelling the market growth.
  • Furthermore, continual technological advancements
    and the integration of third-dimensional (3D)
    imaging, robotics, and artificial intelligence
    (AI) technologies with spine biologics devices to
    assist healthcare professionals in performing
    complex spine surgeries are also positively
    influencing the market growth. Some of the other
    factors contributing to the market growth include
    increasing healthcare expenditure and extensive
    research and development (RD) in medical
    science.
  • Looking forward, the market is anticipated to
    grow at a CAGR of 3.7 during the forecast period
    (2024-2032).
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/spine-biologics-market

5
Report Segmentation
  • Breakup by Product
  • Spinal Allografts
  • Machined Bones Allograft
  • Demineralized Bone Matrix
  • Bone Graft Substitutes
  • Bone Morphogenetic Proteins
  • Synthetic Bone Grafts
  • Cell Based Matrix
  •  
  • Breakup by Surgery Type
  • Open Spine Surgery
  • Minimally Invasive Spine Surgery
  • Breakup by End User
  • Hospitals

6
Report Segmentation
  • Ambulatory Care Centers
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Others
  • Breakup by Region
  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

7
Competitive Landscape with Key Players
  • Arthrex Inc
  • Alphatec Holdings Inc.
  • Exactech Inc
  • Johnson Johnson
  • Medtronic plc
  • NuVasive Inc
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet.

8
Key Questions Answered in the Report
9
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global Spine Biologics
    Market    5.1    Market Overview    5.2  
     Market Performance    5.3    Impact of
    COVID-19  5.4    Market Forecast
  • 6     Market Breakup by Product    6.1    Spinal
    Allografts        6.1.1 Market Trends       
    6.1.2 Key Segments           6.1.2.1 Machined
    Bones Allograft           6.1.2.2 Demineralized
    Bone Matrix        6.1.3 Market Forecast    6.2
       Bone Graft Substitutes        6.2.1 Market
    Trends        6.2.2 Key Segments         
     6.2.2.1 Bone Morphogenetic Proteins         
     6.2.2.2 Synthetic Bone Grafts       

10
Table of Contents
  •         6.2.3 Market Forecast    6.3    Cell
    Based Matrix        6.3.1 Market Trends       
    6.3.2 Market Forecast7   Market Breakup by
    Surgery Type    7.1    Open Spine Surgery     
      7.1.1 Market Trends        7.1.2 Market
    Forecast    7.2    Minimally Invasive Spine
    Surgery        7.2.1 Market Trends        7.2.2
    Market Forecast8   Market Breakup by End User 
      8.1    Hospitals        8.1.1 Market Trends 
          8.1.2 Market Forecast    8.2    Ambulatory
    Care Centers        8.2.1 Market Trends       
    8.2.2 Market Forecast    8.3    Spinal Surgery
    Centers        8.3.1 Market Trends        8.3.2
    Market Forecast    8.4    Orthopedic Clinics   
        8.4.1 Market Trends        8.4.2 Market
    Forecast    8.5    Others        8.5.1 Market
    Trends        8.5.2 Market Forecast
  • For more information, visit https//www.imarcgrou
    p.com/spine-biologics-market/toc

11
Disclaimer
  • 2023 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE 1-631-791-1145 E-MAIL
sales_at_imarcgroup.com
Write a Comment
User Comments (0)
About PowerShow.com